MEDIA ALERT: MAC AIDS Fund Survey Exposes Startlingly ‘No-Risk’ Attitude Amongst UK Women – 73 Percent Admit to Never Being Tested for HIV/AIDS

LONDON, March 1, 2010 – A new UK study from the MAC AIDS Fund (MAF), the philanthropic arm of
Estee Lauder-owned (NYSE: EL) MAC Cosmetics, shockingly reveals prevalent
risky behavior amongst British women due to significant gaps in HIV awareness
and education. Almost three quarters (73 percent) of women in the UK admit
they've never been tested for [...]

Shire Supports Rare Disease Day 2010

CAMBRIDGE, Massachusetts and BASINGSTOKE, England, March 1, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced it will actively support Rare
Disease Day across the world by generating media coverage in many countries
to raise awareness and understanding of rare diseases.

Rare Disease Day seeks to call attention [...]

Elsevier Addresses Today’s Healthcare Information Crisis With a Renewed Focus on Improving Quality and Efficiency

At HIMSS 2010, Elsevier's Top Experts Will Present Strategic and Tactical Solutions to Help Providers Improve Healthcare Quality, Achieve Meaningful Use

PHILADELPHIA, March 1, 2010 – Advancing healthcare quality to help improve patient outcomes
and economic efficiency continues to be a primary focus in 2010 for Elsevier,
the leading publisher of scientific, technical and medical information.
During HIMSS [...]

Gold Standard/Elsevier Launches Clinical Pharmacology Mobile

Reference Tool Puts Real-Time, Evidence-Based Drug Information Onto Mobile Devices at the Point of Care

TAMPA, Florida, March 1, 2010 – Gold Standard/Elsevier (www.goldstandard.com), a
leading provider of drug decision support announced today the availability of
Clinical Pharmacology Mobile, a mobile device-optimized web site offering
users access to the features and functions of Clinical Pharmacology, an
award-winning electronic drug [...]

First Personal Injury Applauds HSE Campaign

MANCHESTER, England, March 1, 2010 – Accident Claims(www.firstpersonalinjury.co.uk/) Solicitors, First
Personal Injury has praised the latest phase of the Health and Safety
Executive's Shattered Lives safety campaign.

The latest phase of the campaign aims to raise awareness of the potential
dangers of trips and falls in the workplace and features some graphic and
hard hitting [...]

Technological Advances Provide a Fillip to the European IV Therapy and Enteral Nutrition Devices Market, Notes Frost & Sullivan

LONDON, March 1, 2010 – The European intravenous (IV) therapy and enteral nutrition devices
market currently offers a highly dynamic and lucrative environment. Advances
in pharmacology and a wider range of blood products have substantially
increased the number of possible drug therapies, which can be used with IV
therapy devices. At the same time, developments in biotechnology are [...]

Catholic Health Initiatives Selects Six of Elsevier’s Online Solutions To Enhance Quality Clinical Decision-Making

Mosby's Nursing Suite and Clinical Pharmacology are now the Primary Decision-support Resources at CHI's 75 Hospitals Across 19 States

PHILADELPHIA, Pennsylvania, March 1, 2010 – Elsevier (www.elsevier.com), a world leader in health
care and medical publishing and online solutions, today announced that
Denver-based Catholic Health Initiatives (www.catholichealthinit.org/
) (CHI), the second-largest faith-based health care system in the nation,
will [...]

Bayer Introduces CONTOUR(R) USB – Innovative Plug and Play Technology That Puts People With Diabetes in the Driving Seat

NEWBURY, England, March 1, 2010 – Today Bayer Diabetes Care launch their new CONTOUR(R) USB
blood glucose meter in the UK and Ireland. Bayer's CONTOUR(R) USB is the
first blood glucose meter with cutting edge 'plug and play' technology and a
built-in USB that inserts directly into a computer. This innovative meter
provides users with instant access to [...]

Health Robotics’ i.v.STATION Robot Proven to be Almost Four Times Faster Than Intelligent Hospital Systems’ RIVA

BOZEN, SUD-TIROL, Italy, March 1, 2010 – Health Robotics today announced the public evaluation of video speed
tests between i.v.STATION and RIVA sterile compounding robots, based on each
companies' public video testimonials at their respective web sites of an
identical powder reconstitution (80 ml) and size/dose of syringe (10cc).
Founded on this side-by-side comparison and other publicly available
information, [...]

CRF Health Reports Record Growth and Earnings

LANSDALE, Pennsylvania, March 1, 2010 – CRF Health, a leading provider of electronic Patient Reported Outcomes
(ePRO) for the life sciences industry, announced record-setting growth and
earnings for 2009. Client commitments grew by 65% and resulted in
record-setting revenue, earnings and backlog. Sales came from both new and
existing clients and the company continues to gain market share. [...]

Torchmark Corporation Elects New Director

MCKINNEY, Texas, March 1, 2010 – Torchmark Corporation (NYSE: TMK) announced that Darren M. Rebelez,
Executive Vice President and Chief Operating Officer of 7-Eleven, Inc., was
elected to its Board of Directors on February 25, 2010. A California native
and Texas resident, Mr. Rebelez holds a B.S. degree in General Engineering
from the United States Military Academy in [...]

Torchmark Corporation Declares Dividend and Resumes Stock Repurchases

MCKINNEY, Texas, March 1, 2010 – Torchmark Corporation (NYSE: TMK) announced that its Board of Directors
has declared a quarterly dividend of US$.15 per share on all of the
outstanding common stock of the Company held of record as of the close of
business of the Company's transfer agent on April 2, 2010. The dividend will
be paid [...]

Teva UK Limited Launches Generic Losartan

CASTLEFORD, England, March 2, 2010 – We are pleased to announce the launch of losartan potassium film-coated
tablets available in 25mg, 50mg and 100mg strengths, in packs of 28. Losartan
is indicated for the treatment of essential hypertension(1).

It is a generic version of Cozaar(R) Black Triangle Drug (losartan)
from MSD and is available [...]

AmpVacs a Broadly Protective Synthetic Influenza A Vaccine

AMSTERDAM, March 2, 2010 – Sanquin Blood Supply Foundation, the Netherlands Cancer Institute, and
the Netherlands Vaccine Institute announce today the launch of their joint
AmpVacs project aiming at the development of a broadly protective synthetic
influenza A vaccine component that in combination with classical
antibody-stimulating vaccines will induce protection against future influenza
A threats.

The [...]

Twenty-Five Years of HIV Blood Testing Helped to Positively Transform Global Health Crisis

ABBOTT PARK, Illinois, March 2, 2010 – Imagine delaying a life-saving surgery or being afraid to receive or
donate blood for fear of contracting HIV (www.who.int/hiv/en/). It
seems unbelievable today, but twenty-five years ago, this was the reality as
the world struggled to keep the deadly virus out of the blood supply.

(Photo: www.newscom.com/cgi-bin/prnh/20100302/CG63179-a)
[...]

ReportsandReports : The Gastrointestinal Market Outlook to 2014: Market Dynamics, Competitive Landscape, Emerging Therapies

DALLAS, March 2, 2010 – ReportsandReports announce to have The Gastrointestinal Market Outlook to
2014: (
www.reportsandreports.com/market-reports/the-gastrointestinal-market-o
utlook-to-2014-market-dynamics-com/) Market dynamics, competitive landscape,
emerging therapies Market Research Report in its store.

(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space [...]

European Authorities Accept Voclosporin for Regulatory Review

Trades on Toronto Stock Exchange – (TSX: ISA)
EDMONTON, Canada, March 2, 2010 – Isotechnika Pharma Inc. (TSX: ISA) today announced that the European
Medicines Agency (EMA) has validated the Marketing Authorization Application
(MAA) filed by its partner, Lux Biosciences, Inc., for voclosporin.
Following validation of the MAA, the dossier is distributed to members of
the Committee for Medicinal [...]

New Evidence Adds to Concerns of Widespread Asbestos Exposure in Schools

LONDON, March 2, 2010 – Shocking new data from a previously unpublished government report was
unveiled today by Clinica MedTech Intelligence, indicating that the problem
of asbestos exposure in schools is worse than previously publicised.

New evidence emerged last week of the suspected widespread failure of UK
schools to observe asbestos safety regulations, heightening [...]

Costly Legacy of the Recession: Employers Risk Mass Exodus of Neglected Staff

ANDOVER, England, March 4, 2010 – A recent survey of the nation's employees carried out by
healthcare provider Simplyhealth has revealed that one in two UK staff say
their mental and physical wellbeing was ignored by their employer during the
economic downturn. A similar number – over 45% – also say that they will
start looking for a [...]

Making a Positive Response to the Closure of the AstraZeneca Charnwood Research Site

NOTTINGHAM, England, March 3, 2010 – Chief Executive of BioCity Nottingham, Dr Glenn Crocker is available to
comment into how the East Midlands might respond to the closure of the
AstraZeneca Charnwood Research Site and offer some positive possibilities in
the aftermath of this bleak event.

In particular Dr Crocker can:

[...]

Stemgent Invests US$4.5 Million, Announces Formation of Ubiquigent, a New UK-Listed Biotechnology Company Based in Dundee, Scotland

New Venture co-founded with Professor Sir Philip Cohen to Focus on the Ubiquitin Proteasome Pathway, a Key Cell Signalling System with Significant Drug Discovery Potential

BOSTON and SAN DIEGO, March 3, 2010 – Stemgent, Inc., a biotechnology company based in San Diego, California,
and Boston, Massachusetts, USA, announced today the formation of Ubiquigent
Ltd, a new biotechnology [...]

Kantar Health Names Ceri Thomas Head of Global Marketing

NEW YORK, March 3, 2010 – Kantar Health, a leading healthcare-focused global consultancy and
marketing insights company, has appointed Ceri Thomas as Head of Global
Marketing. In this role, he will develop and implement Kantar Health's global
marketing strategies. Mr. Thomas is based in Kantar Health's London-area
office.

"Ceri's global experience and perspective, combined with [...]

Further Wins Two Branding Awards at the Transform Awards 2010

LONDON, March 3, 2010 – Further were winners at the Transform Awards 2010 with a Gold for best
rebrand in the public sector for King's Health Partners and Bronze for best
rebrand of a service for Cinven.

Further's work with King's College London and the three NHS Foundation
Trusts of Guy's and St Thomas', [...]

Sensitech’s Groundbreaking TempTale(R)4 USB Dry Ice Temperature Monitor Provides Fast, Simple, Efficient Cold Chain Visibility

BEVERLY, Massachusetts, March 3, 2010 – Sensitech Inc.'s new TempTale(R)4 USB Dry Ice temperature monitor is the
first on the market to offer a self-contained, probeless temperature monitor
with automatic Adobe(R) PDF file generation capabilities and a USB
communications interface. Sensitech, the global leader in cold-chain
visibility solutions, is a wholly owned subsidiary of Carrier Corp., a
business unit [...]

Long Waits for Radiotherapy Linked to Increased Recurrence of Breast Cancer

Professor Karol Sikora Comments on New Research Published in BMJ 3.03.10
LONDON, March 3, 2010 – A large US study published today shows that there is a strong
correlation between delay in accessing radiotherapy for breast cancer and the
incidence of local recurrence. A steady rise in recurrence developed when the
time from surgery to radiotherapy exceeded 8 [...]

Women for Positive Action: an International Partnership Dedicated to Enhancing the Lives of Women Living with HIV

LONDON, March 4, 2010 – To mark International Women's Day (March 8, 2010) Women for Positive
Action are launching a series of tools to raise awareness of the challenges
facing women living with HIV/AIDS today. Women for Positive Action (WFPA) is
led by a broad coalition of healthcare professionals, women living with HIV
and community representatives from Europe, [...]

Medtronic Named Among World’s Most Innovative Companies by MIT Technology Review

Company Recognized for Ground-Breaking Work in the Field of Deep Brain Stimulation

MINNEAPOLIS, March 4, 2010 – Medtronic, Inc. (NYSE: MDT) today announced that it has been selected as
one of Massachusetts Institute of Technology (MIT) Technology Review's 50
most innovative companies. Known as TR50, the first annual list includes
companies that Technology Review believes have demonstrated superiority [...]

Atacama Labs Enters Into Partnership With Excella Gmbh, Which is Part of Fareva Holding, a Top 10 Global Contract Manufacturer

A Finnish Company ATACAMA LABS OY and a German Based EXCELLA GmbH (Fareva Holding SA) Have Signed a Contract Manufacturing Agreement to Jointly Market and Sell PDG Granule and Tablet Manufacturing Services for the Pharmaceutical Industry

HELSINKI, Finland, March 4, 2010 – Atacama Labs Oy has developed an innovative oral drug delivery technology
(called 'pneumatic dry [...]

Genzyme Corporation’s Generous Benefaction to Enable the Creation of a Key Clinical Academic Post for Multiple Sclerosis, Neuroimmunological Diseases

Expands Commitment to University of Cambridge Community
CAMBRIDGE, England, March 4, 2010 – The University of Cambridge announced today that Genzyme Corporation, a
diversified, global biotechnology company with significant operations in
Cambridge and across the United Kingdom, has made a generous benefaction to
endow a key clinical academic post at the university dedicated to the
advancement of fundamental and [...]

First Breast Cancer Patients in Europe to be Treated With Revolutionary Therapy System

VEENENDAAL, The Netherlands, March 4, 2010 – Today the first patients in Europe are to receive treatment for breast
cancer using a revolutionary system called AccuBoost. The Italian hospital
where the patients are being treated is using the technology to pinpoint the
tumour bed and treat it whilst still protecting the patient's healthy
surrounding tissue and organs. This [...]

Isotechnika Pharma Receives National Research Council IRAP Funding for NICAM Program

EDMONTON, Canada, March 4, 2010 – Isotechnika Pharma Inc. (TSX: ISA) today announced that it has received
funding approval from the National Research Council's Industrial Research
Assistance Program (IRAP) for its Non-Immunosuppressive Cyclosporin Analog
Molecules (NICAM) program. The grant of CDN$237,069 will support the
development progress of the NICAM program which is part of an emerging
therapeutic field that [...]

Chinmax Defends its Distribution Rights to Biosite Triage Products, Filing Suit in China against Subsidiary of Inverness Medical Innovations

SHANGHAI, March 8, 2010 – On January 28, 2010, Chinmax Medical Systems, Inc., a leading distributor
of clinical diagnostics in China, filed a civil complaint in the People's
Court of Yangpu District, Shanghai against Inverness Medical Beijing Co.
Ltd., a subsidiary of Inverness Medical Innovations, Inc. (NYSE: IMA).

According to the complaint, Chinmax is [...]

100 Day Countdown to the World Congress of Cardiology Scientific Sessions 2010

Beijing, China, 16-19 June 2010
GENEVA, March 8, 2010 – In 100 days the World Heart Federation, with the support of the Chinese
Society of Cardiology and the Chinese Medical Association, will open the
World Congress of Cardiology (WCC) Scientific Sessions 2010 in Beijing,
China.

Participants from more than 100 countries are expected to attend [...]

Los Angeles Hair Transplant Cosmetic Surgeon Corrects Bad Hair Transplants With New Hair Restoration Method

LOS ANGELES, March 8, 2010 – FineTouch Dermatology, Inc. announces the Body Hair Transplantation (BHT)
hair restoration method. This new method provides patients with the
opportunity to fix bad hair transplants damaged by traditional hair
restoration techniques.

This new and exciting option is now offered by Dr. Sanusi Umar, a Los
Angeles cosmetic surgeon and [...]

Pepal Innovation in India Programme: Development With a Difference

LONDON, March 8, 2010 – Social enterprise, Pepal, launches its new executive development
programme – Innovation in India. Private-sector professionals will work with
Indian non-profit organisations, tackling issues such as HIV/AIDS, child
health and women's rights. Each participant will be paired with a non-profit
partner and after receiving management and innovation training from the LSE
will deliver their own [...]

PROGENSA(R) PCA3 Assay Can Help Guide Repeat Prostate Biopsy Decisions, Data Presented at Leading Medical Meeting Confirm

More Than 2,400 Men Tested in Largest Studies to Date of Gen-Probe's Molecular Urine Test -

SAN DIEGO, March 8, 2010 – Gen-Probe's (Nasdaq: GPRO) PROGENSA(R) PCA3 assay can help determine
whether men suspected of having prostate cancer should undergo a repeat
biopsy, according to data from the two largest studies to date of the
molecular urine test. [...]

Lilly to Acquire European Rights to Pfizer Animal Health Assets

Deal Provides Strategic Fit For Elanco, Lilly's Animal Health Division
GREENFIELD, Indiana, March 8, 2010 – Elanco, the animal health division of Eli Lilly and Company (NYSE: LLY),
today announced that Lilly has signed an agreement to acquire the European
rights to a portfolio of certain Pfizer Animal Health products. The products,
including vaccines, parasiticides and feed additives, [...]

Health care experts revealed the positive effects of sildenafil citrate.

An investigation has been made that revealed the positive effects of the most popular medication for curing impotence amongst men. ??Sildenafil citrate is the basic chemical that serves best in treating and lowering the pains and difficulties faced by men while achieving and maintaining erection. ED or impotence is the most common sexual disorder that [...]

Community Health Solutions of America Engages Chronically Ill Members With MEDai’s Risk Navigator Suite

MEDai's Predictive Analytics and Business Intelligence Tools to Help CHSA Improve Care Management Quality and Employer Reporting

ORLANDO, Florida, March 9, 2010 – Community Health Solutions of America, LLC (CHS) of St. Petersburg, FL,
will help its healthcare clients better manage their patient populations and
track their clinical and financial objectives with quality-focused tools from
MEDai, an Elsevier [...]

West Wireless Health Institute Names Donald Casey to Serve as its CEO

Former Worldwide Chairman of Johnson and Johnson Comprehensive Care Group to Lead Institute's Mission to Accelerate Wireless Health Innovation

SAN DIEGO, March 9, 2010 – The West Wireless Health Institute (WWHI) today announced Donald Casey
has been named the Institute's first chief executive officer (CEO). He will
also serve on the Institute's board of directors. Casey, former [...]

Dmatek Changes its Name to Attenti

TEL AVIV, Israel, March 9, 2010 – Attenti ("The Company"), launches today as one of the largest
and fastest growing providers of remote people monitoring solutions globally.

(Logo: www.newscom.com/cgi-bin/prnh/20100309/381942 )
Attenti, formerly known as Dmatek, provides the technology to
monitor over 50,000 individuals daily around the globe, in the [...]

Autism Care Provider Welcomes the National Autism Strategy

LONDON, March 9, 2010 – Brookdale Care, one of the UK's leading providers of
specialist hospital, residential and supported living services for people
living with Autistic Spectrum Disorders (ASD), has welcomed the publication
of "Rewarding and fulfilling lives: The strategy for adults with autism in
England (2010)."

The autism strategy sets out a clear vision [...]

Housekeepers, Transporters May ‘Inadvertently’ Spread Hospital Infection

They're overlooked, under-protected in infection puzzle
PITTSBURGH, March 9, 2010 – One cause of the rampant international hospital-infection epidemic may be
the "inadvertent exposure" of hospital housekeepers and transporters to
antibiotic-resistant "Superbugs" such as MRSA, says TeleTracking Technologies
CEO Anthony Sanzo (www.teletracking.com).

Sanzo, a former health system CEO, was commenting on a recently-released
study which suggests [...]

Orthopaedic Synergy, Inc. Announces Letter of Intent to Acquire Praxim, SA.

EAST TAUNTON, Massachusetts, March 9, 2010 – Orthopaedic Synergy, Inc., is pleased to announce that it has entered
into a letter of intent and period of exclusivity to acquire Praxim, SA of
France.

"The acquisition of Praxim SA will represent a continuation of the
philosophy of the Orthopaedic Synergy group that good companies can [...]

European Study Suggests Bottle-Fed Infants Most at Risk for Bisphenol A Ingestion, But Exposure Levels Well Below ‘Safe’ Limits

Study reviews more exposure pathways than previous surveys, also concludes additional research needed on production processes for canned soup, canned meat.

ZURICH, Switzerland, March 9, 2010 – Swiss researchers examining exposure pathways for a common chemical used
in plastic containers and linings of cans find infants have the highest
estimated levels of Bisphenol A (BPA), with exposures [...]

Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech

Provides Promising Biologic Intended to Treat Multiple Sclerosis and Compounds that Complement Abbott's Existing Diverse Oncology Program

ABBOTT PARK, Illinois and REDWOOD CITY, California, March 9, 2010 – Abbott (NYSE: ABT) and Facet Biotech Corporation (Nasdaq: FACT) announced
today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's
early- and mid-stage pharmaceutical pipeline. Abbott will acquire [...]

Beware of Getting Caught in the Crossfire, Warns MediCare International

War and Reconstruction Zones now Popular Destinations for Specialist Expatriate Workers

LONDON, March 10, 2010 – As troops return home from Iraq and Afghanistan, the full horror of war
is often hidden from public view. Not only are soldiers killed whilst away on
duty, but many suffer lost limbs or disfigurement when injured by bombs,
explosives and other [...]

European Countries to Agree New Targets to Fight Environmental Threats to Health

New WHO Reports Show Progress in Reducing Environmental Hazards to Health but Growing Inequalities in Exposure

COPENHAGEN and PARMA, Italy, March 10, 2010 – Representatives of 53 Member States from the WHO European Region will
gather in Parma, Italy, on 10-12 March 2010 to review the impact of national
and cross-border environmental policies on the health status [...]

Chronic Kidney Disease and Diabetes – Major Risk Factors Amongst Europe’s Population to Be Urgently Addressed

Event at European Parliament calls for early identification and treatment of chronic kidney disease, especially among at-risk patients

STRASBOURG, France, March 10, 2010 – The European Kidney Health Alliance (EKHA) and World Kidney Day (WKD)
organisations today call for European Union (EU) support. Early awareness,
identification and treatment of chronic kidney disease (CKD) and its
associated diseases, including [...]

BASF Podcast: The Chemical Reporter – What are Fungicides?

LUDWIGSHAFEN, Germany, March 10, 2010 – Just like animals and human beings, plants can get sick. In many cases,
the cause is a fungus. Not a mushroom like you see poking up out of the
ground in the woods, but a network of branching, filamentary cells that
botanists call 'hyphae'. In entertaining episodes our Chemical Reporter
answers questions [...]

Fast Track to Temperature Tracking

YPRES, France, March 10, 2010 – Melexis, an early and innovative semiconductor player in the RFID market,
and ProximaRF, a provider of versatile HF reader solutions, join their forces
to enable fast and easy development of Data Logging applications. The RFID
Sensor Kit (DVK90129) will help implementation of RFID technology in
applications such as cold chain management, industrial [...]

Major New Resource on Kidney Disease for Black and Minority Ethnic Patients

LONDON, March 11, 2010 – Over 3,000,000 people in the UK are at risk of Chronic Kidney Disease
(CKD); 45,000 people in the UK are being treated for kidney failure and the
prevalence of kidney failure is increasing at 5% per year

The Kidney Research UK (www.kidneyresearchuk.org/home.php) and NHS
Kidney Care have launched a [...]

Cordis Unveils Next Generation CoCr Coronary Stent

PRESILLION(TM) PLUS CoCr Coronary Stent Offers New Levels of Delivery, Support and Restoration for Arteriosclerotic Arteries

WATERLOO, Belgium, March 11, 2010 – Cordis Corporation today announced the European launch of its next
generation of bare metal stent system – PRESILLION(TM) PLUS. The new stent
system, which improves upon the ground-breaking PRESILLION(TM), features
important technological advances designed to gain [...]

The Cancer Market Outlook To 2014: Competitive Landscape, Market Size, Pipeline Analysis and Growth Opportunities Now Available on ReportsandReports

DALLAS, March 11, 2010 – ReportsandReports announce it will carry The Cancer Market Outlook To
2014: Competitive landscape, market size, pipeline analysis and growth
opportunities Market Research Report in its Store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/the-cancer-market-outlook-to-2014-competitive-landscape-market-/
(Due to the length of this URL, it may be necessary to copy and [...]

The Electronic Cigarette Company Challenges the Rt Hon Andy Burnham MP to Ban All Tobacco Products on 21st June 2010

Why is the British government legislating in favour of Tobacco in their Flawed MLX 364 document?

BLACKBURN, England, March 11, 2010 – Will the Rt Hon Andy Burnham MP Ban all Tobacco products on 21st June
2010?
The MHRA, the nation's Health regulators, have created for Mr. Burnham a
golden opportunity to ban ALL [...]

New Data Demonstrates Abbott’s Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition

First-of-its-Kind, Catheter-Based Device for Mitral Valve Repair Meets Both Primary Safety and Effectiveness Endpoints Compared to Surgery

ATLANTA, March 14, 2010 – Late-breaking data presented today at the American College of
Cardiology's 59th annual scientific session from the landmark EVEREST II
(Endovascular Valve Edge-to-Edge REpair STudy) trial demonstrated that
Abbott's investigational MitraClip(R) system met both its primary safety [...]

Matrix Corporate Capital and PharmaVentures Announce the Signing of a Memorandum of Understanding (MOU)

LONDON and OXFORD, England, March 15, 2010 – Matrix Corporate Capital ("Matrix") and PharmaVentures Limited
("PharmaVentures") today announced the signing of a Memorandum of
Understanding ("MOU") covering strategic transactions in the biotech,
pharmaceutical and med tech sectors. The companies will work together to
identify licensing, buyout, investment, IPO and consolidation opportunities
which bring together both strategic expertise and capital [...]

Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology

New Data From Second Phase Shows No Blood Clots, No Repeat Procedures and Very Low MACE in Patients Treated with Abbott's Innovative Device

ATLANTA, March 15, 2010 – Abbott (NYSE: ABT) today announced positive 30-day results from the first
101 patients enrolled in the second phase of the ABSORB trial. Patients
treated with Abbott's bioresorbable vascular scaffold [...]

Boston Scientific Announces 1000th European Patient Using LATITUDE(R) Patient Management System

Value of the Service Recognized by Patients and Physicians
PARIS, March 15, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced that
it has reached the milestone of 1000 European patients using its LATITUDE(R)
Patient Management System. The LATITUDE system remotely monitors patients
with implantable cardiac devices, gathering information on both the device
and a patient's heart health status. [...]

New Analysis Suggests Early Initiation of Multaq(R) (dronedarone) Feasible in AF Patients Following Discontinuation of Amiodarone

WYNNEWOOD, Pennsylvania, March 15, 2010 – Data from a post-hoc analysis presented today at the 59th
Annual Scientific Session of the American College of Cardiology in Atlanta,
Georgia, evaluated transition to Multaq(R) (dronedarone) in patients with
atrial fibrillation (AF) or atrial flutter (AFL) following prior treatment
with amiodarone. The data comes from a post-hoc analysis of pooled data [...]

Inadequate Response to Clopidogrel Leads to Higher Incidence of Major Adverse Cardiac Events in Patients Who have Undergone PCI

Results suggest increased need for quantifying patient response to clopidogrel through point-of-care testing

SAN DIEGO, March 15, 2010 – Accumetrics, Inc., a privately-held developer and marketer of the
VerifyNow(R) System, the first rapid and easy-to-use point-of-care system for
measuring platelet reactivity to multiple antiplatelet agents, announced the
presentation of a 2,000 patient meta-analysis examining patient response to
antiplatelet therapy [...]

The Marley Family Announces Partnership With HoMedics to Expand Legacy of Music Legend Bob Marley

Line of Consumer Electronics to Debut in October 2010
CHICAGO, March 15, 2010 – Working together for a better world, reggae musician Bob Marley's Family,
along with HoMedics, introduced The House of Marley in Chicago last night.
Dedicated to benefit people and the planet, The House of Marley is committed
to developing innovative products, adhering to Marley family [...]

Health Robotics Reports Record-Breaking Revenues, EBITDA, Net Profits, and Cash-Flow for its Fiscal Year 2009

BOZEN, Sud-Tirol, Italy, March 15, 2010 – Health Robotics today announced FY2009 results, delivering once again
record levels of revenues, profits and cash flow, overcoming a difficult
global economic climate and the short-term consequences of its decision to
terminate non-performing sales and service channels in North America and
Asia-Pacific.

"We are obviously very proud of [...]

/C O R R E C T I O N – Health Robotics/

BOZEN, Sud-Tirol, Italy, March 15, 2010 – In the news release, "Health Robotics Reports Record-Breaking Revenues,
EBITDA, Net Profits, and Cash-Flow for its Fiscal Year 2009" issued on 15
Mar 2010 13:20 GMT, by Health Robotics over PR Newswire, we are advised by
a representative of the company that "EUR VAR" has been changed to "$ [...]

Healthcare in the Lebanon: Pay Extra Attention Says MediCare International

LONDON, March 15, 2010 -

– The Lebanon is an important centre for international workers
– Post conflict international health cover hard to arrange
– Good hospital facilities can only be accessed with the right cover
– MediCare International offers insurance for [...]

New Board Director Appointed

DUBLIN, March 15, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces the appointment of Bill Burns to its
Board as a Non Executive Director with immediate effect. Mr Burns has also
been appointed a member of Shire's Remuneration Committee.

Mr Burns has a long and distinguished career in [...]

EGE University Hospital in Izmir (Turkey) Establishes Successful VAD Program

BERLIN, March 15, 2010 – Prof. Mustafa ??zbaran, leading surgeon of the VAD program at the EGE
University Hospital in Izmir, implanted for the first time a few days ago the
optimized 3rd generation Berlin Heart INCOR system with its new features. The
surgeon recalls "The implantation went very well, there were no
complications." Two years ago, Prof. [...]

Cheetah Medical Closes $20 Million Series B Financing

Accelerating the Global Commercialization of NICOM(R) Noninvasive Hemodynamic Monitoring Systems

TEL-AVIV, Israel, March 15, 2010 – Cheetah Medical, a worldwide leader in noninvasive hemodynamic and
cardiac output monitoring technology, announced today the closing of a $20
million financing round. The financing was led by Ascension Health Ventures
(AHV) and also included Robert Bosch Venture Capital (RBVC), MVM Life [...]

Only 17% of Children Trust Dad for Advice About Bullying

Bullying a Major Concern for Kids
LONDON, March 15, 2010 – New research out today reveals that while most dads (61%) feel
comfortable giving advice to their children about bullying only 1 in 5 (17%)
children trust their dad's advice on this topic. However 6 out of 10 (59%)
children would trust their mum's advice.

[...]

4-Antibody Announces a Long-Term Collaboration With Boehringer Ingelheim for Therapeutic Antibodies

BASEL, Switzerland, March 16, 2010 – 4-Antibody AG today announces a major long-term collaboration with
Boehringer Ingelheim to discover and to develop fully human therapeutic
antibodies for a number of targets in various disease indications. 4-Antibody
will use its proprietary and unencumbered Hu-PAC(R) and Retrocyte Display(R)
technologies for the discovery and development of fully human antibodies
against novel targets [...]

PERSEUS Trial Results Demonstrate Positive Safety and Efficacy Outcomes for Boston Scientific’s Novel Platinum Chromium TAXUS(R) Element(TM) Stent System

NATICK, Massachusetts and ATLANTA, Georgia, March 16, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced
12-month results from its PERSEUS clinical program that demonstrated positive
safety and efficacy outcomes in workhorse lesions for the platinum chromium
TAXUS(R) Element(TM) Paclitaxel-Eluting Stent System compared to the TAXUS(R)
Express2(TM) Paclitaxel-Eluting Stent System. The results also reported a
similar safety profile and [...]

‘Listen To Your Brain,’ World’s First Neuromarketing Music Video, Launches From NeuroFocus

Four-Minute Production Praised As 'Funnier Than Any Film At South By Southwest'

BERKELEY, California, March 16, 2010 – The tweets flew fast and furious at the famous South By Southwest Music,
Film, & Interactive Festival in Austin, Texas when "Listen To Your Brain"
(www.youtube.com/user/neurofocus#p/a/u/0/RUzo7fhRpFY) began playing on
the big screen.
Created by NeuroFocus, the world's [...]

Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals

DUBLIN, March 16, 2010 – Shire plc (LSE: SHP, NASDAQ; SHPGY), announces that it has received a
Paragraph IV Notice Letter from Teva Pharmaceuticals USA, Inc. ("Teva")
advising of the filing of an Abbreviated New Drug Application ("ANDA") for a
generic version of Shire's 1 mg, 2mg, 3 mg, and 4mg guanfacine hydrochloride
extended release tablets, INTUNIV(TM).

[...]

Ingenuity Systems Announces New Distributor for Greece, Turkey and the Balkans

REDWOOD CITY, California, March 17, 2010 – Ingenuity Systems, the leading provider of information solutions for life
science researchers, has selected Biodiagnostics as its new distributor of
IPA(R) in Greece, Turkey and the Balkan countries. IPA is the leading
software application to model, analyze, and understand the complex biological
and chemical systems at the core of life science [...]

A New Mobile Phone as “Life-insurance” for Millions of Heart Patients

New: a Modern Touch Screen Mobile Phone With an Integrated Electrocardiogram

BERLIN, March 17, 2010 – The H'andy sana 210 mobile phone is a high-quality touch screen mobile
phone with all the functions, such as a camera, MP3 player, file manager,
organizer, additional memory, etc., and that little extra: an integrated
electrocardiogram.
In the UK, [...]

Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum

Groundbreaking partnerships focused on healthcare value could benefit patients and transform the global healthcare marketplace -

EVANSTON, Illinois, March 17, 2010 – Executives from pharmaceutical companies and health care payer and
provider organizations convened at the "Selling Pharmaceuticals in 2015"
forum in Philadelphia to discuss mutually beneficial partnerships that, if
implemented, could replace the traditional model of selling [...]

Global Partners Join Forces to Speed Development of New TB Drug Combinations

FDA applauds effort to take years off development of much needed TB treatments

WASHINGTON, March 18, 2010 – Ahead of World TB Day, US Food and Drug Administration Commissioner
Margaret Hamburg helped public and private sector partners launch a new
collaboration to significantly accelerate the development of combination
treatments for tuberculosis – and replace an almost 50-year-old drug [...]

Denmark’s Odense University Hospital Works To Make Elekta VMAT Its Mainstream Radiation Therapy Technique

Faster arc-based method could help increase the number of patient treatments per day

ODENSE, Denmark, March 18, 2010 – Odense University Hospital (OUH, Odense, Denmark), a major
multi-specialty medical center serving southern Denmark, joined the global
community of Elekta VMAT
(www.elekta.com/healthcare_international_elekta_vmat.php) clinical
sites last fall when it began treating patients with the arc-based technique.
With Elekta VMAT, single or multiple [...]

American Public Health Champion Receives 2010 Stockholm Water Prize

STOCKHOLM, Sweden, March 22, 2010 – Dr. Rita Colwell, distinguished Professor from the University of Maryland
and John Hopkins University's Bloomberg School of Public Health in the United
States, has been named the 2010 Stockholm Water Prize Laureate. Dr. Colwell's
pioneering research on the prevention of waterborne infectious diseases has
helped protect the health and lives of millions.

[...]

First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity

Spasticity Affects a Significant Number of Post-Stroke Patients, [1],[2],[3] and Many are not Adequately Treated by Standard Therapy [4]

TOLOCHENAZ, Switzerland, March 23, 2010 – Medtronic, Inc. (NYSE: MDT) today announced the enrollment of
the first European patients in the largest randomized controlled trial to
date to investigate the benefits of ITB Therapy(R) (Intrathecal Baclofen) in
post-stroke patients [...]

US District Court Returns Binding Verdict of Invalidity of Two Claims of Covidien Patent Covering Trocar Seal Technology

Applied Medical to Pursue Post-Trial Motions to Overturn Covidien Infringement Verdict

ORANGE COUNTY, California, March 23, 2010 – Applied Medical announced today that a United States District Court jury
for the Eastern District of Texas returned a binding verdict of invalidity of
two claims of a Covidien patent covering trocar seal technology.
Applied Medical [...]

Frost & Sullivan: Visual Collaboration in the Future of Healthcare

Frost & Sullivan to Host Analyst Briefing on Visual Collaboration in Healthcare Industry on Thursday, 1 April 2010 at 14.00 BST

LONDON, March 23, 2010 – Evolving patients' needs, limited number of medical specialists in remote
areas, and technological advances are some of the most important factors
driving interest in visual collaboration in healthcare. Patients become
keener to [...]

New Report: BSR’s HERproject Empowers Women and Improves Business in Six Countries

SAN FRANCISCO, March 23, 2010 – BSR's (www.bsr.org) HERproject (www.herproject.org) — a
factory-based women's health initiative — has significantly improved women's
health awareness, leadership skills, and relationships with their employers,
according to a new BSR report
(www.bsr.org/reports/BSR_HERproject_Investing_In_Women.pdf) revealing
results of research conducted after the first year of HERproject programs in
China, Egypt, India, Mexico, Pakistan, and Vietnam.

[...]

Boston Scientific Announces Availability of New Connector System Designed to Simplify the Implant Procedure for Cardiac Devices

PARIS, March 24, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced
European commercial availability of the Company's new cardiac rhythm
management connector system, which consists of the ENDOTAK RELIANCE(R) 4-SITE
defibrillation lead and compatible COGNIS(R) cardiac resynchronization
therapy defibrillators (CRT-Ds) and TELIGEN(R) implantable cardioverter
defibrillators (ICDs). The system is designed to simplify the implant
procedure by combining three terminals [...]

Property Industry has Critical Role in Improving Well-being in Britain

LONDON, March 24, 2010 – A new report launched today, Building Quality of Life,
commissioned by Development Securities PLC, one of the UK's leading property
companies, reveals the huge pressures on our general happiness and well-being
and the key contribution that the property industry can make to improving
quality of life in Britain.

The research, [...]

ViroPharma Announces Acceptance of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Marketing Authorization Application (MAA) by European Medicines Agency (EMA)

EXTON, Pennsylvania, March 24, 2010 – ViroPharma Incorporated (Nasdaq: VPHM) today announced that the European
Medicines Agency (EMA) has accepted the filing of its Marketing Authorization
Application (MAA) for Cinryze for acute treatment and prophylaxis against
hereditary angioedema (HAE), which was submitted through the centralized
procedure in March 2010. ViroPharma is seeking European approval for both
prevention and treatment [...]

The CPM Resource Center Healthcare Consortium Earns Prestigious Award From The National Academies of Practice Interdisciplinary Group Recognition Award Lauds CPM Resource Center’s Healthcare Consortium

GRAND RAPIDS, Michigan, March 24, 2010 – The Healthcare Consortium of the Clinical Practice Model
Resource Center (CPMRC, www.cpmrc.com/), an Elsevier company, is the
2010 recipient of the National Academies Practice (NAP) Interdisciplinary
Group Recognition Award. Bestowed annually on groups that make "enduring
contributions to interdisciplinary education and practice," the NAP
(www.napractice.org/ ) award recognizes CPMRC's 25-year-old Healthcare
Consortium of [...]

Agendia Launches BluePrint(TM) Expanding Breast Cancer Product Offering

New Service to Provide Breast Cancer Molecular Subtyping
HUNTINGTON BEACH, California and AMSTERDAM, March 24, 2010 – Agendia, a world leader in molecular cancer diagnostics, today announced
that its breast cancer product offering, consisting of breast cancer
recurrence test MammaPrint(R), and TargetPrint(TM), has been expanded with
BluePrint (TM) to report important additional information on tumor subtypes.
This new service [...]

Shire Presents Positive Data for Patients With Type 1 Gaucher Disease Who Switched to VPRIV(TM)

Also Reported are Results of Retrospective Analysis of Phase I/II Study, Showing Success in Reaching Therapeutic Goals within 4 Years of Initiation of Treatment

CAMBRIDGE, Massachusetts, March 25, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today presented positive data from a Phase III
clinical trial (TKT-034) designed to evaluate the safety [...]

Boston Scientific Announces Availability of New Connector System Designed to Simplify the Implant Procedure for Cardiac Devices

PARIS, March 24, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced
European commercial availability of the Company's new cardiac rhythm
management connector system, which consists of the ENDOTAK RELIANCE(R) 4-SITE
defibrillation lead and compatible COGNIS(R) cardiac resynchronization
therapy defibrillators (CRT-Ds) and TELIGEN(R) implantable cardioverter
defibrillators (ICDs). The system is designed to simplify the implant
procedure by combining three terminals [...]

Property Industry has Critical Role in Improving Well-being in Britain

LONDON, March 24, 2010 – A new report launched today, Building Quality of Life,
commissioned by Development Securities PLC, one of the UK's leading property
companies, reveals the huge pressures on our general happiness and well-being
and the key contribution that the property industry can make to improving
quality of life in Britain.

The research, [...]

ViroPharma Announces Acceptance of Cinryze(TM) (C1 Esterase Inhibitor [Human]) Marketing Authorization Application (MAA) by European Medicines Agency (EMA)

EXTON, Pennsylvania, March 24, 2010 – ViroPharma Incorporated (Nasdaq: VPHM) today announced that the European
Medicines Agency (EMA) has accepted the filing of its Marketing Authorization
Application (MAA) for Cinryze for acute treatment and prophylaxis against
hereditary angioedema (HAE), which was submitted through the centralized
procedure in March 2010. ViroPharma is seeking European approval for both
prevention and treatment [...]

The CPM Resource Center Healthcare Consortium Earns Prestigious Award From The National Academies of Practice Interdisciplinary Group Recognition Award Lauds CPM Resource Center’s Healthcare Consortium

GRAND RAPIDS, Michigan, March 24, 2010 – The Healthcare Consortium of the Clinical Practice Model
Resource Center (CPMRC, www.cpmrc.com/), an Elsevier company, is the
2010 recipient of the National Academies Practice (NAP) Interdisciplinary
Group Recognition Award. Bestowed annually on groups that make "enduring
contributions to interdisciplinary education and practice," the NAP
(www.napractice.org/ ) award recognizes CPMRC's 25-year-old Healthcare
Consortium of [...]

Agendia Launches BluePrint(TM) Expanding Breast Cancer Product Offering

New Service to Provide Breast Cancer Molecular Subtyping
HUNTINGTON BEACH, California and AMSTERDAM, March 24, 2010 – Agendia, a world leader in molecular cancer diagnostics, today announced
that its breast cancer product offering, consisting of breast cancer
recurrence test MammaPrint(R), and TargetPrint(TM), has been expanded with
BluePrint (TM) to report important additional information on tumor subtypes.
This new service [...]

FDA Advisory Panel Unanimously Recommends Expanded Indication for Boston Scientific’s Heart Failure Devices Based on Landmark MADIT-CRT Trial

Company's CRT-Ds Recommended for Asymptomatic and Mild Heart Failure Patients

NATICK, Massachusetts, March 23, 2010 – Boston Scientific Corporation (NYSE: BSX) today announced that the
Circulatory System Devices Panel of the U.S. Food and Drug Administration
(FDA) has unanimously recommended approval of an expanded indication for its
cardiac resynchronization therapy defibrillators (CRT-Ds), including the
COGNIS(R) CRT-D. The panel recommended [...]

First European Patients Enrolled in Largest Ever Randomised Controlled Trial of ITB Therapy(R) in Post-Stroke Patients With Severe Spasticity

Spasticity Affects a Significant Number of Post-Stroke Patients, [1],[2],[3] and Many are not Adequately Treated by Standard Therapy [4]

TOLOCHENAZ, Switzerland, March 23, 2010 – Medtronic, Inc. (NYSE: MDT) today announced the enrollment of
the first European patients in the largest randomized controlled trial to
date to investigate the benefits of ITB Therapy(R) (Intrathecal Baclofen) in
post-stroke patients [...]

US District Court Returns Binding Verdict of Invalidity of Two Claims of Covidien Patent Covering Trocar Seal Technology

Applied Medical to Pursue Post-Trial Motions to Overturn Covidien Infringement Verdict

ORANGE COUNTY, California, March 23, 2010 – Applied Medical announced today that a United States District Court jury
for the Eastern District of Texas returned a binding verdict of invalidity of
two claims of a Covidien patent covering trocar seal technology.
Applied Medical [...]

Frost & Sullivan: Visual Collaboration in the Future of Healthcare

Frost & Sullivan to Host Analyst Briefing on Visual Collaboration in Healthcare Industry on Thursday, 1 April 2010 at 14.00 BST

LONDON, March 23, 2010 – Evolving patients' needs, limited number of medical specialists in remote
areas, and technological advances are some of the most important factors
driving interest in visual collaboration in healthcare. Patients become
keener to [...]

New Report: BSR’s HERproject Empowers Women and Improves Business in Six Countries

SAN FRANCISCO, March 23, 2010 – BSR's (www.bsr.org) HERproject (www.herproject.org) — a
factory-based women's health initiative — has significantly improved women's
health awareness, leadership skills, and relationships with their employers,
according to a new BSR report
(www.bsr.org/reports/BSR_HERproject_Investing_In_Women.pdf) revealing
results of research conducted after the first year of HERproject programs in
China, Egypt, India, Mexico, Pakistan, and Vietnam.

[...]

First Personal Injury on Asbestos in Schools

MANCHESTER, England, March 22, 2010 – Accident claims (www.firstpersonalinjury.co.uk/) solicitors, First
Personal Injury, want to see more advice made readily available to parents
and pupils about asbestos exposure in schools. The call comes less than a
month after a report by the Asbestos Training and Consultancy Association
(ATAC) made news for all the wrong reasons.

[...]

American Public Health Champion Receives 2010 Stockholm Water Prize

STOCKHOLM, Sweden, March 22, 2010 – Dr. Rita Colwell, distinguished Professor from the University of Maryland
and John Hopkins University's Bloomberg School of Public Health in the United
States, has been named the 2010 Stockholm Water Prize Laureate. Dr. Colwell's
pioneering research on the prevention of waterborne infectious diseases has
helped protect the health and lives of millions.

[...]

Theranostics Paves the Way for Personalised Medicine in Europe, Says Frost & Sullivan

LONDON, March 22, 2010 – Theranostics is an emerging field in clinical diagnostics, focussing on
developing specific analysis to predict the most suitable drug for a patient
along with assessing the efficacy of the drug. It uses molecular assays to
determine the optimum dose of drugs for a patient, paving the way for
personalised medicine. Although significant awareness [...]

PRISYM ID’s Medica Greatly Simplifies FDA and MHRA Compliance

Web-Based Solution Allows Faster Rollout, Greater Collaboration and Increased Accuracy When Labelling Pharmaceuticals and Medical Devices

DUBLIN, March 23, 2010 – PRISYM ID Limited today announced the launch of a new product
that allows life science companies to review, validate and record their
product labels quickly and efficiently while allowing greater collaboration
across the process. PRISYM Medica is [...]

Menicon Co. Acquires Tomey Co. to Improve Competitiveness

Menicon takes another step to global expansion by vertical integration -
NAGOYA, Japan, March 19, 2010 – Menicon Co., Ltd. announced on March 17 that it had acquired all shares
of Tomey Co., Ltd. from Tomey Shoji Inc. The deal was completed on February
1, 2010.

Tomey Co. is a major Japan-based manufacturer of [...]

Evidence Suggests That Sleep is a Common Problem for People With a Wide Range of Neurological Conditions

UCB Supports World Sleep Day (19th March 2010)
BRUSSELS, Belgium, March 19, 2010 – Patients with neurological diseases need more help with their associated
sleep-wake disturbances that can often make their underlying illness worse,
say leading sleep specialists attending a sleep meeting hosted by
biopharmaceutical company, UCB, to mark World Sleep Day.

A growing body [...]

Activeion Announces Opening of European Office

Activeion (Europe) GmbH commences operations as the wholly owned subsidiary of Activeion Cleaning Solutions, Rogers, Minnesota, USA

BADEN, Switzerland, March 19, 2010 – Activeion Cleaning Solutions LLC, Rogers, MN USA is proud to announce its
new European subsidiary, Activeion (Europe) GmbH. Activeion (Europe) GmbH
will distribute and market the ionator EXP(TM) throughout Europe, the Middle
East and Africa. [...]

Nobel Prize Winner Dr. Eric Kandel Joins NeuroFocus Advisory Board

Columbia University Professor and Noble Laureate for His Contributions to Neuroscience Brings Expertise in Memory Research to World's Leading Neuromarketing Company

BERKELEY, California, March 19, 2010 – NeuroFocus, the world's leading neuromarketing company, announced today
that Nobel Prize laureate Eric R. Kandel, M.D., has joined its Advisory
Board. Dr. Kandel is a winner of the Nobel Prize [...]

Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers

CAMBRIDGE, England, March 19, 2010 – Mundipharma announced today that the Committee for Medicinal
Products for Human Use (CHMP) of the European Medicines Agency (EMA) has
issued a positive opinion recommending that marketing authorisations can be
granted in Germany and the following Member States of the EU: Austria,
Belgium, Denmark, Finland, France, Ireland, Italy, Luxembourg, Norway,
Poland, Spain and [...]

Eisai Plans to Continue Eritoran (E5564) Phase III Severe Sepsis Trial, Based on Interim Analysis That Evaluated Efficacy and Safety Data

LONDON, March 26, 2010 – Eisai Europe Ltd. announced today that the Phase III ACCESS (A Controlled
Comparison of Eritoran and Placebo in Patients with Severe Sepsis) trial of
the investigational compound eritoran (E5564) will continue enrolling to the
planned 2,000 patients. As part of a planned interim analysis, an independent
Data Monitoring Committee (DMC) has evaluated efficacy [...]

Shire Presents Positive Data for Patients With Type 1 Gaucher Disease Who Switched to VPRIV(TM)

Also Reported are Results of Retrospective Analysis of Phase I/II Study, Showing Success in Reaching Therapeutic Goals within 4 Years of Initiation of Treatment

CAMBRIDGE, Massachusetts, March 25, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today presented positive data from a Phase III
clinical trial (TKT-034) designed to evaluate the safety [...]

PharmaTelevision Appoints Managing Director

OXFORD, England, March 29, 2010 – PharmaVentures, the global corporate advisory serving the biotechnology
and pharmaceutical industry, is pleased to announce the appointment of Anne
Vindenes Allen as Managing Director of its new subsidiary, PharmaTelevision
Ltd.

PharmaTelevision is the leading television company dedicated to assisting
biopharma companies in their business information and communication needs. In
addition [...]

CSL Limited Publishes First Corporate Responsibility Report

MELBOURNE, Australia, March 29, 2010 – CSL Limited (ASX: CSL), Australia's leading biopharmaceutical company,
has released its first Corporate Responsibility Report, combining information
about the Company's economic, social and environmental performance for 2009.

"CSL has experienced significant growth over the past 10 years, which has
been underpinned by our commitment to conducting our business [...]

Health Robotics Launches i.v.SOFT Global Beta Installation Program at the European Association of Hospital Pharmacists

BOZEN, Sud-Tirol, Italy, March 29, 2010 – Health Robotics today announced the successful global launch of the Beta
Installation kick-off for its 3 latest i.v.SOFT Workflow Engine software
automation modules [Assist, Label+ and Profile] in Nice [France], the 2010
venue for the European Association of Hospital Pharmacists. i.v.SOFT helps
Pharmacy Technicians, I.V. Room Supervisors, and Pharmacy Directors to
compound [...]

Hoya Corporation Appoints Chris Japp Global President of Hoya (Pentax) Lifecare Division

TOKYO, March 29, 2010 – Hoya Corporation announced the appointment of Chris N. Japp to the
position of Global President, Hoya (Pentax) Lifecare Division.

"Hoya Corporation is extremely pleased to have Chris Japp lead the global
division for Lifecare," said Hiroshi Hamada, COO of Hoya Corporation. "Chris
brings a wealth of knowledge, insight and [...]

Sanofi-aventis: Multaq(R) Receives Positive Recommendation by NICE in New Appraisal Consultation Document

PARIS, March 30, 2010 – Sanofi-aventis (EURONEXT: SAN, and NYSE: SNY) announced today
that the National Institute for Health and Clinical Excellence (NICE) in
England and Wales, has just published a new appraisal consultation document
(ACD)[1] for Multaq(R) (dronedarone) indicating its intention to recommend
Multaq(R) use for the management of patients with atrial fibrillation (AF).

[...]

New Intervention Priority Score in Elsevier’s MTM 360 to Enhance Medicare Medication Therapy Management Efforts

ORLANDO, Florida, March 30, 2010 – Elsevier Clinical Decision Support, a leading provider of
medical information and solutions, announced today that it has developed a
quantitative ranking system that enables health plans to better control their
medication therapy management (MTM) programs for Medicare Part D members.

The Intervention Priority Score (IPS) is a new [...]

New Drug Application for Voclosporin Accepted for Priority Review by FDA

EDMONTON, Canada, March 30, 2010 – Isotechnika Pharma Inc. (TSX: ISA) today announced that the New Drug
Application (NDA) for the Company's next generation calcineurin inhibitor,
voclosporin, has been accepted for priority review as filed by the U.S.
Food and Drug Administration (FDA). The application was submitted by
Isotechnika's partner, Lux Biosciences, Inc.

The [...]

Safelayer Consolidates its Strategic Alliance With Indra for Citizen e-ID/e-Passport Solutions

Both Companies Foresee an Increase in Demand for the new Generations of Citizen Identification Solutions for the Coming Years

BARCELONA, March 30, 2010 – Safelayer Secure Communications (www.safelayer.com) -
leader in the security and trust market for information and communication
technologies – consolidates its strategic alliance with the multinational
Indra for its international expansion. The companies are currently [...]

Hospira Completes Acquisition of Orchid’s Generic Injectable Pharmaceuticals Business

LAKE FOREST, Illinois, March 30, 2010 – — Gains New Manufacturing Capabilities and Expands Global Reach –

Hospira, Inc. (NYSE: HSP), the world leader in generic injectable
pharmaceuticals, today announced it has completed the acquisition of the
generic injectable pharmaceuticals business of Orchid Chemicals &
Pharmaceuticals Ltd. (BSE: 524372, NSE: ORCHIDCHEM), a leading Indian
pharmaceuticals [...]

Informex Specialty Chemical Conference Announces Keynote & Speakers

PRINCETON, New Jersey, March 30, 2010 – Informex Show Management today announced the keynote speaker for the
inaugural Informex Specialty Chemicals Conference, to be held in Houston,
Texas on May 11th, will be Lee E. Mikles*, President and CEO of FutureFuel
Corp., the leading US manufacturer of biofuels and specialty chemicals.
Launched in response to industry feedback and [...]